Literature DB >> 22649244

Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors.

Adrian F Lozada1, Xulong Wang, Natalia V Gounko, Kerri A Massey, Jingjing Duan, Zhaoping Liu, Darwin K Berg.   

Abstract

Glutamate is the primary excitatory transmitter in adult brain, acting through synapses on dendritic spines and shafts. Early in development, however, when glutamatergic synapses are only beginning to form, nicotinic cholinergic excitation is already widespread; it is mediated by acetylcholine activating nicotinic acetylcholine receptors (nAChRs) that generate waves of activity across brain regions. A major class of nAChRs contributing at this time is a species containing α7 subunits (α7-nAChRs). These receptors are highly permeable to calcium, influence a variety of calcium-dependent events, and are diversely distributed throughout the developing CNS. Here we show that α7-nAChRs unexpectedly promote formation of glutamatergic synapses during development. The dependence on α7-nAChRs becomes clear when comparing wild-type (WT) mice with mice constitutively lacking the α7-nAChR gene. Ultrastructural analysis, immunostaining, and patch-clamp recording all reveal synaptic deficits when α7-nAChR input is absent. Similarly, nicotinic activation of α7-nAChRs in WT organotypic culture, as well as cell culture, increases the number of glutamatergic synapses. RNA interference demonstrates that the α7-nAChRs must be expressed in the neuron being innervated for normal innervation to occur. Moreover, the deficits persist throughout the developmental period of major de novo synapse formation and are still fully apparent in the adult. GABAergic synapses, in contrast, are undiminished in number under such conditions. As a result, mice lacking α7-nAChRs have an altered balance in the excitatory/inhibitory input they receive. This ratio represents a fundamental feature of neural networks and shows for the first time that endogenous nicotinic cholinergic signaling plays a key role in network construction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649244      PMCID: PMC3370670          DOI: 10.1523/JNEUROSCI.6246-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  64 in total

Review 1.  Structural and functional diversity of native brain neuronal nicotinic receptors.

Authors:  Cecilia Gotti; Francesco Clementi; Alice Fornari; Annalisa Gaimarri; Stefania Guiducci; Irene Manfredi; Milena Moretti; Patrizia Pedrazzi; Luca Pucci; Michele Zoli
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

2.  Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis.

Authors:  Cagla Eroglu; Nicola J Allen; Michael W Susman; Nancy A O'Rourke; Chan Young Park; Engin Ozkan; Chandrani Chakraborty; Sara B Mulinyawe; Douglas S Annis; Andrew D Huberman; Eric M Green; Jack Lawler; Ricardo Dolmetsch; K Christopher Garcia; Stephen J Smith; Z David Luo; Arnon Rosenthal; Deane F Mosher; Ben A Barres
Journal:  Cell       Date:  2009-10-08       Impact factor: 41.582

Review 3.  Nicotine addiction and nicotinic receptors: lessons from genetically modified mice.

Authors:  Jean-Pierre Changeux
Journal:  Nat Rev Neurosci       Date:  2010-06       Impact factor: 34.870

Review 4.  Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system.

Authors:  Jian-xin Shen; Jerrel L Yakel
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

5.  Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors.

Authors:  Chongbo Zhong; Chuang Du; Melissa Hancock; Marjolijn Mertz; David A Talmage; Lorna W Role
Journal:  J Neurosci       Date:  2008-09-10       Impact factor: 6.167

6.  Direction-specific disruption of subcortical visual behavior and receptive fields in mice lacking the beta2 subunit of nicotinic acetylcholine receptor.

Authors:  Lupeng Wang; Krsna V Rangarajan; Courtney A Lawhn-Heath; Rashmi Sarnaik; Bor-Shuen Wang; Xiaorong Liu; Jianhua Cang
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

7.  Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion.

Authors:  Maria Elena Avale; Philippe Faure; Stéphanie Pons; Patricia Robledo; Thierry Deltheil; Denis J David; Alain M Gardier; Rafael Maldonado; Sylvie Granon; Jean-Pierre Changeux; Uwe Maskos
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-02       Impact factor: 11.205

8.  Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice.

Authors:  Edward D Levin; Ann Petro; Amir H Rezvani; Ninitia Pollard; N Channelle Christopher; Mariel Strauss; Jessica Avery; Jessica Nicholson; Jed E Rose
Journal:  Behav Brain Res       Date:  2008-09-11       Impact factor: 3.332

Review 9.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

10.  Instantaneous modulation of gamma oscillation frequency by balancing excitation with inhibition.

Authors:  Bassam V Atallah; Massimo Scanziani
Journal:  Neuron       Date:  2009-05-28       Impact factor: 17.173

View more
  69 in total

1.  Microtubule dynamics at the growth cone are mediated by α7 nicotinic receptor activation of a Gαq and IP3 receptor pathway.

Authors:  Jacob C Nordman; Nadine Kabbani
Journal:  FASEB J       Date:  2014-03-31       Impact factor: 5.191

2.  Lateral mobility of presynaptic α7-containing nicotinic receptors and its relevance for glutamate release.

Authors:  David Gomez-Varela; Darwin K Berg
Journal:  J Neurosci       Date:  2013-10-23       Impact factor: 6.167

3.  Activation of α7 nicotinic acetylcholine receptors increases intracellular cAMP levels via activation of AC1 in hippocampal neurons.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  Neuropharmacology       Date:  2015-04-29       Impact factor: 5.250

4.  Neonatal nicotine exposure increases excitatory synaptic transmission and attenuates nicotine-stimulated GABA release in the adult rat hippocampus.

Authors:  Joanne C Damborsky; William H Griffith; Ursula H Winzer-Serhan
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

5.  Cortical parvalbumin GABAergic deficits with α7 nicotinic acetylcholine receptor deletion: implications for schizophrenia.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; Stewart A Anderson; David R Lynch
Journal:  Mol Cell Neurosci       Date:  2014-06-28       Impact factor: 4.314

6.  Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor.

Authors:  Hui-Qiu Wu; Masahiro Okuyama; Yasushi Kajii; Ana Pocivavsek; John P Bruno; Robert Schwarcz
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

7.  Neuroprotective activity of hydroponic Teucrium polium following bilateral ovariectomy.

Authors:  K V Simonyan; V A Chavushyan
Journal:  Metab Brain Dis       Date:  2014-12-13       Impact factor: 3.584

8.  Ly6h regulates trafficking of alpha7 nicotinic acetylcholine receptors and nicotine-induced potentiation of glutamatergic signaling.

Authors:  Clare A Puddifoot; Meilin Wu; Rou-Jia Sung; William J Joiner
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

9.  Cortical synaptic NMDA receptor deficits in α7 nicotinic acetylcholine receptor gene deletion models: implications for neuropsychiatric diseases.

Authors:  Hong Lin; Fu-Chun Hsu; Bailey H Baumann; Douglas A Coulter; David R Lynch
Journal:  Neurobiol Dis       Date:  2013-12-08       Impact factor: 5.996

10.  Prenatal Primary Prevention of Mental Illness by Micronutrient Supplements in Pregnancy.

Authors:  Robert Freedman; Sharon K Hunter; M Camille Hoffman
Journal:  Am J Psychiatry       Date:  2018-03-21       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.